CW
MRNA icon

CreativeOne Wealth’s Moderna MRNA Stock Holding History

CreativeOne Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
+22,494
New +$1.16M 0.03% 429
2025
Q3 		– Sell
-9,821
Closed -$271K – 1188
2025
Q2 		$271K Buy
9,821
+1,040
+12% +$27.4K 0.01% 962
2025
Q1 		$249K Buy
+8,781
New +$312K 0.01% 922
2023
Q3 		– Sell
-3,344
Closed -$406K – 735
2023
Q2 		$406K Buy
3,344
+23
+0.7% +$3.07K 0.02% 556
2023
Q1 		$510K Buy
3,321
+1,682
+103% +$277K 0.03% 464
2022
Q4 		$294K Buy
+1,639
New +$268K 0.02% 576
2022
Q3 		– Sell
-1,463
Closed -$209K – 744
2022
Q2 		$209K Buy
1,463
+201
+16% +$28.7K 0.01% 669
2022
Q1 		$217K Sell
1,262
-1,251
-50% -$211K 0.01% 680
2021
Q4 		$638K Buy
2,513
+401
+19% +$117K 0.03% 388
2021
Q3 		$813K Sell
2,112
-970
-31% -$358K 0.05% 295
2021
Q2 		$724K Buy
3,082
+589
+24% +$105K 0.04% 309
2021
Q1 		$326K Buy
+2,493
New +$361K 0.02% 425

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

CreativeOne Wealth's MRNA Position: Q2 2026 in Review

CreativeOne Wealth opened a new position in Moderna (MRNA) in Q2 2026: 22,494 shares worth $1.58M. The stake represents 0.03% of the portfolio and ranks #429 among its holdings. This is a return to the name: CreativeOne Wealth previously reported a position in MRNA as recently as Q2 2025.

CreativeOne Wealth first reported a position in MRNA in Q1 2021 and has held it in 12 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • CreativeOne Wealth held 22,494 shares of Moderna worth $1.58M as of Q2 2026.
  • Moderna was a new CreativeOne Wealth position in Q2 2026.
  • Moderna made up 0.03% of CreativeOne Wealth's portfolio in Q2 2026, its #429 holding.
  • CreativeOne Wealth first reported a position in Moderna in Q1 2021 and has held it in 12 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.